The use of more than one inotrope in acute heart failure is associated with increased mortality: A multi-centre observational study

Acute Cardiac Care

Volumn 10, Issue 4, 2008, Pages 209-213

  Rossinen, Juhani ^a,d   Harjola, Veli Pekka ^a   Siirila Waris, Krista ^a   Lassus, Johan ^a   Melin, John ^b   Peuhkurinen, Keijo ^c   Nieminen, Markku S ^a  

^a Division of Cardiology   (Finland)

^b Central Hospital of Middle Finland   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute heart failure; Inotropes

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; LEVOSIMENDAN; NORADRENALIN;

ACUTE HEART FAILURE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOGENIC SHOCK; CONTROL GROUP; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OLIGURIA; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CATECHOLAMINES; FEMALE; FINLAND; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; HYDRAZONES; LENGTH OF STAY; MALE; MIDDLE AGED; PYRIDAZINES; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 56749182205     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940802262376     Document Type: Article

References (9)

1. The Task Force on Acute Heart Failure of the European Society of Cardiology. Guidelines on the diagnosis and treatment of heart failure. Eur Heart J. 2005;26:384-416.
2. Kellum JA, Pinsky MR. Use of vasopressor agents in critically ill patients. Crit Care. 2002;8:236-41.
3. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. J Am Coll Cardiol. 2005;46:57-64.
4. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: Description of population. Eur Heart J. 2006;27:2725-36.
5. Tavazzi L, Maggioni A, Lucci D, Cacciatore G, Ansalone G, Oliva F, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207-15.
6. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006;27:1908-20.
7. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196-202.
8. Shah MR, Hasselblad V, Stevenson LW, Binanay C, O'Connor CM, Sopko G, et al. Impact of the Pulmonary Artery Catheter in Critically Ill Patients. JAMA. 2005;294:1664-70.
9. Gonzalez-Vilchez F, Ayuela J, Ares M, Mata NS, Gonzalez AG, Duran RM, et al. Comparison of Doppler echocardiography, color M-mode Doppler, and Doppler tissue imaging for the estimation of pulmonary capillary wedge pressure. J Am Soc of Echocardiog. 2002;15:1245-50.